← Back to Search

Other

Capsaicinoid for Drug Tolerance

Phase 1
Waitlist Available
Led By S Mark Taylor, MD FRCSC
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-treatment and immediate (1 hour after treatment)
Awards & highlights

Study Summary

This trial is testing whether capsaicin can reduce the symptoms of rhinitis.

Eligible Conditions
  • Drug Tolerance
  • Allergic Rhinitis
  • Capsaicin

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-treatment and immediate (1 hour after treatment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-treatment and immediate (1 hour after treatment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Lacrimation - Likert - Change from 1 hour after pre-treatment baseline
Lacrimation - Likert - Change from 1 week after pre-treatment baseline
Pain - Likert - Change from 1 hour after pre-treatment baseline
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intranasal CapsaicinExperimental Treatment1 Intervention
Separate patients will be given escalating doses of intranasal capsaicinoid spray

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
257 Previous Clinical Trials
83,784 Total Patients Enrolled
S Mark Taylor, MD FRCSCPrincipal InvestigatorDalhousie University
David WA Forner, MDStudy DirectorDalhousie University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025